Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
2.740
-0.145 (-5.03%)
At close: Nov 20, 2026, 4:00 PM EST
2.730
-0.010 (-0.36%)
After-hours: Nov 20, 2026, 7:30 PM EST
Verrica Pharmaceuticals Revenue
Verrica Pharmaceuticals had revenue of $6.91M in the quarter ending September 30, 2026, a decrease of -51.80%. This brings the company's total for the last twelve months to $22.89M, down -25.75% year-over-year. In the year 2025, Verrica Pharmaceuticals had annual revenue of $35.58M with 370.22% growth. That makes Verrica Pharmaceuticals the 33,080th largest company in the world by revenue and 4,329th in the United States.
Revenue (ttm)
$22.89M
Revenue Growth
-25.75%
P/S Ratio
2.06
Revenue / Employee
$301,197
Employees
76
Market Cap
47.07M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 35.58M | 28.01M | 370.22% |
| Dec 31, 2024 | 7.57M | 2.44M | 47.66% |
| Dec 31, 2023 | 5.12M | -3.91M | -43.27% |
| Dec 31, 2022 | 9.03M | -2.97M | -24.73% |
| Dec 31, 2021 | 12.00M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Heron Therapeutics | 148.22M |
| Tonix Pharmaceuticals Holding | 43.05M |
| Spero Therapeutics | 41.56M |
| Werewolf Therapeutics | 21.00M |
| RenovoRx | 2.78M |
| Clene | 238.00K |
VRCA News
- 2 days ago - Verrica Pharmaceuticals Transcript: Jefferies Global Healthcare Conference - Transcripts
- 9 days ago - Verrica Pharmaceuticals reports Q3 EPS (58c), consensus (49c) - TheFly
- 9 days ago - Verrica Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 9 days ago - Verrica Pharmaceuticals Earnings release: Q3 2026 - Filings
- 9 days ago - Verrica Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 9 days ago - Verrica Pharmaceuticals Reports Third Quarter 2026 Financial Results - GlobeNewsWire
- 11 days ago - Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 16 days ago - Verrica Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026 - GlobeNewsWire